This study is looking at whether a blood thinner called Lovenox (enoxaparin) can help prevent problems in future pregnancies for women who have had a difficult pregnancy before. These past problems could include early delivery, stillbirth, a baby born smaller than expected, or severe high blood pressure during pregnancy. Researchers want to see if using Lovenox, guided by information from a previous placenta, can reduce the chance of these problems happening again. You could be eligible if you are between 18 and 60 years old and have experienced one of these adverse pregnancy outcomes in a prior pregnancy. The study aims to see if Lovenox can prevent or lessen these issues. The current recruitment status is unclear, and the study plans to enroll 20 participants.

Study design

This is an interventional study where participants will be randomly assigned to either receive Lovenox or standard care. It plans to enroll 20 participants.

What's involved

You would provide blood samples at several points during the study. If assigned to the Lovenox group, you would take the medication daily from 12 weeks of pregnancy until 36 weeks.

Compensation

Not stated in the trial record.

Follow-up

Your progress will be followed from enrollment through 6 weeks postpartum (after childbirth).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.